Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.

Trial Identifier: PSK00009
Sponsor: Sanofi
Start Date: October 2020
Primary Completion Date: August 2021
Study Completion Date: January 2022
Condition: Pneumococcal Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
UNITED STATES, California Anaheim, California, UNITED STATES, 92804
UNITED STATES, California Rolling Hills Estates, California, UNITED STATES, 90274
UNITED STATES, Colorado Wheat Ridge, Colorado, UNITED STATES, 80033
UNITED STATES, Florida Jacksonville, Florida, UNITED STATES, 32216
UNITED STATES, Florida Miami, Florida, UNITED STATES, 33173
UNITED STATES, Idaho Meridian, Idaho, UNITED STATES, 83642
UNITED STATES, Indiana Valparaiso, Indiana, UNITED STATES, 46383
UNITED STATES, Louisiana Metairie, Louisiana, UNITED STATES, 70006
UNITED STATES, Nebraska Lincoln, Nebraska, UNITED STATES, 68516
UNITED STATES, Nevada Las Vegas, Nevada, UNITED STATES, 89106
UNITED STATES, New Jersey Newark, New Jersey, UNITED STATES, 07103
UNITED STATES, North Dakota Fargo, North Dakota, UNITED STATES, 58104
UNITED STATES, Ohio Columbus, Ohio, UNITED STATES, 43213
UNITED STATES, Oregon Medford, Oregon, UNITED STATES, 97504
UNITED STATES, Pennsylvania Pittsburgh, Pennsylvania, UNITED STATES, 15236
UNITED STATES, South Carolina North Charleston, South Carolina, UNITED STATES, 29405
UNITED STATES, Utah Salt Lake City, Utah, UNITED STATES, 84107